Medlive Technology Co (FRA:1JZ) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1JZ Medlive Technology Co Ltd FRA:1JZ
90 GF Score
Price €0.84
GF Value €1.61
! 5 Warning Signs
View Full Analysis

What is Medlive Technology Co Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:1JZ
90GF Score
Medlive Technology Co Ltd FRA:1JZ
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medlive Technology Co (FRA:1JZ) Overvalued in 2026?

Based on GuruFocus' analysis, Medlive Technology Co stock appears to be undervalued. The current stock price of €0.84 is trading 47.6% below its estimated GF Value™ of €1.61.

Key valuation signals for FRA:1JZ:

  • Dividends Received:
  • GF Value™: €1.61 vs. price of €0.84 (47.6% below fair value)
  • GF Score™: 90/100 with 5 warning signs

No single metric tells the full story. See the FRA:1JZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medlive Technology Co Business Description

Other Exchanges 02192:Hong Kong
Address Huangqu East Road No. 5, Courtyard Building 4, Yimaitong Mansion, Chaoyang District, Beijing, CHN
Medlive Technology Co Ltd is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms. The company developed into a professional provider of medical information services and precision digital marketing services. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and a SaaS solution that helps with medical conferences and clinical research.
90GF Score

Get the complete analysis for FRA:1JZ

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.84
Price
€1.61
GF Value